Clinical Commissioning Policy: Clinical Commissioning Policy:

First Page		Document Content
Date: 2014-08-12 08:05:41 Medicine Immunosuppressants Autoimmune diseases Neurological disorders Glatiramer acetate Natalizumab Fingolimod McDonald criteria Interferon Immunology Multiple sclerosis Immune system		Clinical Commissioning Policy: Clinical Commissioning Policy: Add to Reading List Source URL: www.england.nhs.uk Download Document from Source Website File Size: 523,92 KB Share Document on Facebook

	Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2 DocID: 1rmwo - View Document
	Clinical Commissioning Policy: Clinical Commissioning Policy: DocID: 18nwv - View Document
	clinical MRI brain imaging Sarah Skinner This article forms part of our ‘Tests and results’ series for 2013, which aims to provide information about common tests that general practitioners order regularly. DocID: 17vg9 - View Document
	Monte Carlo simulation of the Spearman-Kaerber TCID50 DocID: 12Yyh - View Document
	[removed]MSJ19110.1177/1352458512445944Absoud et al.Multiple Sclerosis Journal MULTIPLE SCLEROSIS MSJ DocID: 10Wuq - View Document